3026 - 3050 of 6324 Results
Title
Year
-
OPENTitle: The ADORA1 mutation linked to early-onset Parkinson’s disease alters adenosine A1-A2A receptor heteromer formation and functionJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113896End Page: 113896Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113896Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113896Citation Count: 11
-
OPENTitle: Changes in CD163+, CD11b+, and CCR2+ peripheral monocytes relate to Parkinson’s disease and cognitionJournal Name: Brain, Behavior, and ImmunityPublisher: Elsevier BVVol: 101Issue #:Start Page: 182End Page: 193Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbi.2022.01.005Best OA location URL: https://doi.org/10.1016/j.bbi.2022.01.005Citation Count: 43
- Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's disease2021OPENTitle: Deep brain stimulation effect on anterior pallidum reduces motor impulsivity in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 23End Page: 31Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2021.11.006Best OA location URL: https://doi.org/10.1016/j.brs.2021.11.006Citation Count: 6
-
OPENTitle: Pharmacological inhibition of AIMP2 aggregation attenuates α-synuclein aggregation and toxicity in Parkinson’s diseaseJournal Name: Biomedicine & PharmacotherapyPublisher: Elsevier BVVol: 156Issue #:Start Page: 113908End Page: 113908Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.biopha.2022.113908Best OA location URL: https://doi.org/10.1016/j.biopha.2022.113908Citation Count: 6
-
OPENTitle: Protective Factors That Maintain Asymptomatic Longevity in Untreated Congenitally Corrected Transposition of Great ArteriesJournal Name: CJC OpenPublisher: Elsevier BVVol: 4Issue #: 3Start Page: 355End Page: 355Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.cjco.2021.11.004Best OA location URL: http://www.cjcopen.ca/article/S2589790X21003012/pdfCitation Count: 0
-
OPENTitle: Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trialJournal Name: Brain StimulationPublisher: Elsevier BVVol: 15Issue #: 3Start Page: 857End Page: 860Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brs.2022.05.012Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X22000912/pdfCitation Count: 19
-
OPENTitle: Identification of risk genes for Alzheimer’s disease by gene embeddingJournal Name: Cell GenomicsPublisher: Elsevier BVVol: 2Issue #: 9Start Page: 100162End Page: 100162Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162Best OA location URL: https://doi.org/10.1016/j.xgen.2022.100162Citation Count: 21
-
OPENTitle: Alpha synuclein, the culprit in Parkinson disease, is required for normal immune functionJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110090End Page: 110090Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110090Best OA location URL: http://www.cell.com/article/S2211124721015813/pdfCitation Count: 83
-
OPENTitle: Mitochondrial ROS promotes susceptibility to infection via gasdermin D-mediated necroptosisJournal Name: CellPublisher: Elsevier BVVol: 185Issue #: 17Start Page: 3214End Page: 3231.e23Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2022.06.038Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9531054Citation Count: 271
-
OPENTitle: Aβ oligomer concentration in mouse and human brain and its drug-induced reduction ex vivoJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 5Start Page: 100630End Page: 100630Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100630Best OA location URL: http://www.cell.com/article/S2666379122001550/pdfCitation Count: 26
-
OPENTitle: Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer’s diseaseJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 29Issue #: 12Start Page: 1637End Page: 1652.e6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.stem.2022.11.010Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10093780/pdf/nihms-1885174.pdfCitation Count: 130
-
OPENTitle: Mitochondrial hyperfusion via metabolic sensing of regulatory amino acidsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 40Issue #: 7Start Page: 111198End Page: 111198Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2022.111198Best OA location URL: http://www.cell.com/article/S2211124722010154/pdfCitation Count: 28
- Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline2022OPENTitle: Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive declineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 95Issue #:Start Page: 70End Page: 76Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.002Citation Count: 32
-
OPENTitle: Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 52End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.005Citation Count: 2
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 10
-
OPENTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Citation Count: 7
-
OPENTitle: Smoking is associated with age at disease onset in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 79End Page: 83Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005Citation Count: 5
-
OPENTitle: Motor and psychiatric features in idiopathic blepharospasm: A data-driven cluster analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 94End Page: 98Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11187571Citation Count: 11
-
OPENTitle: Atypical antipsychotic use and mortality risk in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 103Issue #:Start Page: 17End Page: 22Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.08.013Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11000674Citation Count: 7
-
OPENTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 2
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 15
-
OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Citation Count: 8
-
OPENTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.017Citation Count: 7
-
OPENTitle: Auto-annotating sleep stages based on polysomnographic dataJournal Name: PatternsPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 100371End Page: 100371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.patter.2021.100371Best OA location URL: https://doi.org/10.1016/j.patter.2021.100371Citation Count: 23
-
OPENTitle: Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 98Issue #:Start Page: 72End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.04.001Citation Count: 2